ORIGINAL PAPER
Association between adenotonsillar hypertrophy and sickle cell disease in adolescents
More details
Hide details
1
Department of Medicine, Federal University of Sergipe, São Cristóvão, Brazil
Submission date: 2019-10-31
Final revision date: 2019-12-04
Acceptance date: 2019-12-04
Publication date: 2019-12-31
Pediatr Pol 2019;94(6):347-350
KEYWORDS
TOPICS
ABSTRACT
Aim of the study:
To assess the association between sickle cell disease and adenotonsillar hypertrophy in adolescents.
Material and methods:
The study group consisted of adolescents aged between 12 and 16 years with sickle cell disease. The control group consisted of adolescents of the same age group who did not have this disorder. The adolescents underwent oropharyngoscopy and transnasal endoscopy. The palatine tonsils were classified according to Brodsky’s criteria, and those with grade three or four were considered hypertrophic. Regarding the pharyngeal tonsil, two criteria were adopted. It was considered obstructive when there was minimal occlusion of the choanae of 50%, and when the obstruction was equal to or greater than 70%. Adenotonsillar hypertrophy was diagnosed when the pharyngeal tonsils and/or palatine tonsils were obstructive.
Results:
In the study group, 31.3% of the adolescents had hypertrophic palatine tonsils, and in the control group, 2.6% exhibited that condition (p < 0.001). With respect to the pharyngeal tonsils, when the criterion of minimal obstruction of the choanae was 50%, 54.2% of the adolescents of the study group and 15.8% of the control group were diagnosed with hypertrophy (p < 0.001). When the criterion for minimal occlusion of the choanae was 70%, the frequency was 35.4% in the study group, and 7.9% in the control group (p = 0.004). Regarding adenotonsillar hypertrophy, when the criterion of the occlusion of the choanae was 50%, it occurred in 58.3% of the adolescents of the study group and 18.4% of the control group (p < 0.001). When the criterion for minimal obstruction of the choanae was 70%, it was observed that adenotonsillar hypertrophy occurred in 45.8% of the adolescents of the study group and in 10.5% of the control group (p < 0.001).
Conclusions:
Adenotonsillar hypertrophy was associated with sickle cell disease in adolescents.
REFERENCES (23)
1.
Beckers K, Dhaese T, Vandewal I, et al. (Adeno)tonsillectomy: what is the impact on the immune system? B-ENT 2017; 13: 177-182.
2.
Ikinciogullari A, Dogu F, Ikinciogullari A, et al. Is immune system influenced by adenotonsillectomy in children? Int J Pediatr Otorhinolaryngol 2002; 66: 251-257.
3.
Serjeant GR, Serjeant BE. Sickle cell disease. Oxford University Press, Oxford 2001.
4.
Okoli K, Irani F, Horvath W. Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies. Med Hypotheses 2009; 72: 578-580.
5.
Strauss T, Sin S, Marcus CL, et al. Upper airway lymphoid tissue size in children with sickle cell disease. Chest 2012; 142: 94-100.
6.
Warrier R, Chauhan A, Athale U. Tonsillectomy and adenoidectomy of obstructive sleep apnea in sickle cell anemia. Indian J Pediatr 2010; 77: 669-672.
7.
Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am 1989; 36: 1551-1569.
8.
Salles C, Ramos RTT, Daltro C, et al. Association between adenotonsillar hypertrophy, tonsillitis and painful crises. J Pediatr (Rio J) 2009; 85: 249-253.
9.
Valera FCP, Avelino MAG, Pettermann MB, et al. OSAS in children: correlation between endoscopic and polysomnographic findings. Otolaryngol Head Neck Surg 2005; 132: 268-272.
10.
Abou-Elhamd KA. Otorhinolaryngological manifestations of sickle cell disease. Int J Pediatr Otorhinolaryngol 2012; 76: 1-4.
11.
Valtonen HJ, Blongren, Qvarnberg YH. Consequences of adenoidectomy in conjunction with tonsillectomy in children. Int J Pediatr Otorhinolaryngol 2000; 30: 105-109.
12.
Hata M, Asakura K, Saito H, et al. Profile of immunoglobulin production in adenoids and tonsil lymphocytes. Acta Otolaryngol 1996; 523: 84-86.
13.
Samuels MP, Stebbens VA, Davies SC, et al. Sleep related upper airway obstruction and hypoxemia in sickle cell disease. Arch Dis Child 1992; 67: 925-929.
14.
Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoid size in children: adenoidal-nasopharyngeal ratio. Am J Roentgenol 1979; 133: 401-404.
15.
Romeo DM, Bruni O, Brogna C, et al. Application of Sleep Disturbance Scale for Children (SDSC) in preschool age. Eur J Pediatr Neurol 2013; 17: 374-382.
16.
D’Ávila JS, Naves AB, Chagas L, et al. Adenoidectomia: novos princípios. Estudo interdisciplinar. Rev Bras Otorrinolaringol 1999; 65: 511-516.
17.
Góis CRT, D`Ávila JS, Cipolotti R, et al. Adenotonsillar hypertrophy in pre-school children with sickle cell disease and diagnostic accuracy of the sleep disturbance scale for children. Int Arch Otorhinolaryngol 2018; 22: 55-59.
18.
Maddern BR, Reed HT, Ohene-Frempong K, Beckerman RC. Obstructive sleep apnea syndrome in sickle cell disease. Ann Otol Rhinol Laryngol 1989; 98: 174-178.
19.
Raj AB, O`Brien LM, Bertolone SJ, et al. Cerebral oximetry improves detection of sickle cell patients at risk of nocturnal cerebral hypoxia. Pediatr Pulmonol 2006; 41: 1088-1094.
20.
Kang K-T, Chou C-H, Weng W-C, et al. Associations between adenotonsillar hypertrophy, age and obesity in children with obstructive sleep apnea. Plos One 2013; 8: 1-8.
21.
Cho D-Y, Sinha SR, Gardner JM, et al. Effect of intratonsillar injection of steroids on the palatine tonsils of rabbits. Laryngoscope 2014; 124: 2811-2817.
22.
Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995; 95: 355-364.
23.
Al-Ghamdi SA, Manoukian JJ, Morielli A, et al. Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotosillar hypertrophy? Laryngoscope 1997; 107: 1382-1387.